Stocks News

LAST PRICE
0.7000
TODAY'S CHANGE (%)
Trending Down-0.0200 (-2.7778%)

Bid / Lots
0.6800/ 21
Ask / Lots
0.7200/ 1
Open / Previous Close
0.7200 / 0.7200
Day Range
Low 0.7000
High 0.7200
52 Week Range
Low 0.5200
High 7.7900
Volume
29,007
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 22, 2024
- Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q, from 4:45PM ET on Friday Nov 22, 2024 by Dow Jones
  4:45PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: OCEA
  
  Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
  
  PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the "Form 10-Q"), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the "SEC").

Nov 21, 2024
- Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical Trial, from 2:00PM ET on Thursday Nov 21, 2024 by Accesswire
  2:00PM ET on Thursday Nov 21, 2024 by Accesswire
  Companies Mentioned: CLCS
- Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical Trial, from 8:02AM ET on Thursday Nov 21, 2024 by Dow Jones
  8:02AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: CLCS
Nov 19, 2024
- Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook, from 9:01AM ET on Tuesday Nov 19, 2024 by PR Newswire
  9:01AM ET on Tuesday Nov 19, 2024 by PR Newswire
  Companies Mentioned: CVKD
- Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook, from 9:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  9:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: CVKD
Nov 13, 2024
- *DJ News On Atlantic Coastal Acquisition Corp. II (ACAB) Now Under ABP, from 5:08PM ET on Wednesday Nov 13, 2024 by Dow Jones
  5:08PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: ABP
- *DJ News On Abpro Corp. (ABPC.XX) Now Under ABP, from 5:08PM ET on Wednesday Nov 13, 2024 by Dow Jones
  5:08PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: ABP
Nov 12, 2024
- CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS, from 9:01AM ET on Tuesday Nov 12, 2024 by PR Newswire
  9:01AM ET on Tuesday Nov 12, 2024 by PR Newswire
  Companies Mentioned: CVKD
- CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS, from 9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
  9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: CVKD
Nov 11, 2024
- DJ Cadrenal Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 1:06PM ET on Monday Nov 11, 2024 by Dow Jones
  1:06PM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: CVKD
Nov 7, 2024
- *DJ Athira Pharma 3Q Loss/Shr 75c >ATHA, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: ATHA

Ocean Biomedical Inc
NASDAQ:OCEAUnited States
NASDAQ FSI:E. Delinquent (Issuer missed regulatory filing deadline)

Search Criteria

Nov 22, 2024

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q, from 4:45PM ET on Friday Nov 22, 2024 by Dow Jones

Peers Headlines

Nov 21, 2024

Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical Trial, from 2:00PM ET on Thursday Nov 21, 2024 by Accesswire

Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical Trial, from 8:02AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 19, 2024

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook, from 9:01AM ET on Tuesday Nov 19, 2024 by PR Newswire

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook, from 9:00AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 13, 2024

*DJ News On Atlantic Coastal Acquisition Corp. II (ACAB) Now Under ABP, from 5:08PM ET on Wednesday Nov 13, 2024 by Dow Jones

*DJ News On Abpro Corp. (ABPC.XX) Now Under ABP, from 5:08PM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 12, 2024

CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS, from 9:01AM ET on Tuesday Nov 12, 2024 by PR Newswire

CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS, from 9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones

Nov 11, 2024

DJ Cadrenal Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 1:06PM ET on Monday Nov 11, 2024 by Dow Jones

Nov 7, 2024

*DJ Athira Pharma 3Q Loss/Shr 75c >ATHA, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones